Addressing the spectrum of hypercholesterolemia

Scott M Grundy, Ernest L. Mazzaferri

Research output: Contribution to journalArticle

Abstract

The past decade has seen a major shift in management: Trials of HMG-CoA reductase inhibitors have suggested that cholesterol reduction offers greater protection against coronary artery disease than does antihypertensive therapy. Five patient vignettes provide guidelines for initiating therapy. The agents should be prescribed with restraint, often not until other measures have been exhausted.

Original languageEnglish (US)
Pages (from-to)43-60
Number of pages18
JournalHospital Practice
Volume31
Issue number6
StatePublished - Jul 3 1996

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Addressing the spectrum of hypercholesterolemia'. Together they form a unique fingerprint.

  • Cite this